Outlook Therapeutics' Lytenava has become the first ophthalmic formulation ... and Avastin is included as a formulary option for wet AMD in most NHS Trusts. In its guidance, NICE said that ...

A comprehensive literature review was conducted for all medications on the formulary of Bedlam Clinic ... Health Technology Assessment Database, and NHS Economic Evaluation Database.

Pfizer’s JAK/TEC inhibitor Litfulo has been recommended for NHS use as a treatment for hair loss caused by severe alopecia areata, the first drug therapy for a condition that affects around ...

NPR's Up First is the news you need to start your day. The three biggest stories of the day, with reporting and analysis from NPR News — in 10 minutes. Available weekdays at 6:30 a.m. ET ...